NCT00043667View on ClinicalTrials.gov

Daclizumab Injections to Treat Non-Infectious Sight-Threatening Uveitis

PHASE2CompletedINTERVENTIONAL

Enrollment

15

Participants

Timeline

Start Date

August 31, 2002

Study Completion Date

October 31, 2004

Conditions

Uveitis

Interventions

DRUG

Daclizumab

Trial Locations (1)

20892

National Eye Institute (NEI), Bethesda

All Listed Sponsors

lead

National Eye Institute (NEI)

NIH

NCT00043667 - Daclizumab Injections to Treat Non-Infectious Sight-Threatening Uveitis | Biotech Hunter | Biotech Hunter